Home
ACIU
ACIU News

Latest AC Immune SA (ACIU) News on November 21, 2024

AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit

Pharmaceutical Technology

6 days ago

AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit

AC Immune reports interim results from Phase 2 trial of ACI-7104.056

TipRanks

6 days ago

AC Immune reports interim results from Phase 2 trial of ACI-7104.056

MT Newswires

7 days ago

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT Newswires

7 days ago

AC Immune Shares Gain Following Positive Clinical Results of Potential Parkinson's Treatment

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

GlobeNewswire

7 days ago

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

AC Immune to Present at the Jefferies 2024 London Healthcare Conference

GlobeNewswire

8 days ago

AC Immune to Present at the Jefferies 2024 London Healthcare Conference

AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Simply Wall St.

12 days ago

AC Immune SA Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Associated Press Finance

16 days ago

AC Immune: Q3 Earnings Snapshot

AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewswire

16 days ago

AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29%

Simply Wall St.

24 days ago

AC Immune SA (NASDAQ:ACIU) stock most popular amongst individual investors who own 32%, while private equity firms hold 29%

What To Expect From AC Immune SA (ACIU) Q3 2024 Earnings

GuruFocus.com

a month ago

What To Expect From AC Immune SA (ACIU) Q3 2024 Earnings

MT Newswires

2 months ago

Sector Update: Health Care Stocks Steady Premarket Tuesday

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

AC Immune Expects $29 Million Milestone Payment From Janssen

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease

GlobeNewswire

2 months ago

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease

FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic

Medical Device Network

3 months ago

FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic

MT Newswires

3 months ago

AC Immune's Partner Life Molecular Gets FDA Fast Track Designation for PET Imaging Agent

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions

GlobeNewswire

3 months ago

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions

The past three years for AC Immune (NASDAQ:ACIU) investors has not been profitable

Simply Wall St.

3 months ago

The past three years for AC Immune (NASDAQ:ACIU) investors has not been profitable

AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates

Zacks

3 months ago

AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates

Associated Press Finance

3 months ago

AC Immune: Q2 Earnings Snapshot

AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewswire

3 months ago

AC Immune Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024

GlobeNewswire

4 months ago

AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024

MT Newswires

4 months ago

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires

4 months ago

Sector Update: Health Care

MT Newswires

4 months ago

AC Immune Shares Surge After Active-Immunotherapy Candidate Gets FDA Fast Track Designation for Alzheimer's Disease

AC Immune wins FDA fast track for Alzheimer’s vaccine

Pharmaceutical Technology

4 months ago

AC Immune wins FDA fast track for Alzheimer’s vaccine

AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease

GlobeNewswire

4 months ago

AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease

AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024

GlobeNewswire

4 months ago

AC Immune Showcasing its Novel Morphomer-Antibody Drug Conjugate (morADC) Platform for the Treatment of Neurodegenerative Diseases at AAIC 2024

Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet

Simply Wall St.

5 months ago

Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune

Zacks

5 months ago

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune

AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?

Simply Wall St.

5 months ago

AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?

MT Newswires

6 months ago

--BTIG Starts AC Immune With Buy Rating, $8 Price Target

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024

GlobeNewswire

6 months ago

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024

Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company

Simply Wall St.

6 months ago

Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company

MT Newswires

6 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires

6 months ago

Sector Update: Health Care

MT Newswires

6 months ago

Top Midday Gainers

Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy

Pharmaceutical Technology

6 months ago

Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy

Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune

BioPharma Dive

6 months ago

Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune

MT Newswires

6 months ago

Top Premarket Gainers

MT Newswires

6 months ago

Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate

Associated Press Finance

6 months ago

AC Immune: Q1 Earnings Snapshot

AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewswire

6 months ago

AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

GlobeNewswire

6 months ago

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth

Simply Wall St.

7 months ago

We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth

Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%

Simply Wall St.

8 months ago

Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update

GlobeNewswire

8 months ago

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update

AC Immune Announces Upcoming Presentations at AD/PD™ 2024

GlobeNewswire

9 months ago

AC Immune Announces Upcoming Presentations at AD/PD™ 2024

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael

Zacks

9 months ago

AbbVie (ABBV) Announces Appointment of New CEO Robert Michael

GeNeuro Launches an Offering With a Commitment to Subscribe by Existing Shareholders and Announces Its Cash Position at December 31, 2023

Business Wire

10 months ago

GeNeuro Launches an Offering With a Commitment to Subscribe by Existing Shareholders and Announces Its Cash Position at December 31, 2023

Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround

Zacks

10 months ago

Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround

4 Best Breakout Stocks to Buy for Superlative Returns

Zacks

10 months ago

4 Best Breakout Stocks to Buy for Superlative Returns

5 Relative Price Strength Stocks Compelling Enough to Buy

Zacks

10 months ago

5 Relative Price Strength Stocks Compelling Enough to Buy

Best Value Stocks to Buy for January 29th

Zacks

10 months ago

Best Value Stocks to Buy for January 29th

Univest Financial Corporation (NASDAQ:UVSP) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Univest Financial Corporation (NASDAQ:UVSP) Q4 2023 Earnings Call Transcript

BJ’s Restaurants, Dell, and More Stocks See Action From Activist Investors

Barrons.com

10 months ago

BJ’s Restaurants, Dell, and More Stocks See Action From Activist Investors

Reuters

10 months ago

UPDATE 1-Bank of America bonuses for dealmakers, traders are broadly flat -source

Bank of America bonuses for dealmakers, traders are broadly flat -source

Reuters

10 months ago

Bank of America bonuses for dealmakers, traders are broadly flat -source

Esquire Financial Holdings Full Year 2023 Earnings: In Line With Expectations

Simply Wall St.

10 months ago

Esquire Financial Holdings Full Year 2023 Earnings: In Line With Expectations

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2023 DIVIDENDS

PR Newswire

10 months ago

SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2023 DIVIDENDS

Amalgamated Financial Corp. Reports Fourth Quarter 2023 Financial Results: $170.8 Million Deposit Growth Excluding Brokered CDs; Net Interest Margin Rises to 3.44%

GlobeNewswire

10 months ago

Amalgamated Financial Corp. Reports Fourth Quarter 2023 Financial Results: $170.8 Million Deposit Growth Excluding Brokered CDs; Net Interest Margin Rises to 3.44%

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

StockStory

10 months ago

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

Oatly and Carvel partner to bring dairy-free flavors to stores nationwide

Food Dive

10 months ago

Oatly and Carvel partner to bring dairy-free flavors to stores nationwide

PubMatic to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

GlobeNewswire

10 months ago

PubMatic to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

AC Immune to Regain Global Rights to Crenezumab and Semorinemab

GlobeNewswire

10 months ago

AC Immune to Regain Global Rights to Crenezumab and Semorinemab

Reuters

10 months ago

CORRECTED-SEC probes B. Riley deals with client tied to failed hedge fund - Bloomberg News

Is Trending Stock Ardmore Shipping Corporation (ASC) a Buy Now?

Zacks

10 months ago

Is Trending Stock Ardmore Shipping Corporation (ASC) a Buy Now?

AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?

Zacks

10 months ago

AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?

Shareholders Would Not Be Objecting To Franklin Covey Co.'s (NYSE:FC) CEO Compensation And Here's Why

Simply Wall St.

10 months ago

Shareholders Would Not Be Objecting To Franklin Covey Co.'s (NYSE:FC) CEO Compensation And Here's Why

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?

Benzinga

10 months ago

Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?

Here’s Why B Riley Financial (RILY) Fell in Q4

Insider Monkey

10 months ago

Here’s Why B Riley Financial (RILY) Fell in Q4

Star Group, L.P. Declares Quarterly Distribution of 16.25 Cents per Unit

GlobeNewswire

10 months ago

Star Group, L.P. Declares Quarterly Distribution of 16.25 Cents per Unit

Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

GlobeNewswire

10 months ago

Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

5 Small-Cap Stocks to Play the January Effect

Zacks

10 months ago

5 Small-Cap Stocks to Play the January Effect

VALNEVA - Declaration of shares and voting rights: December 31, 2023

GlobeNewswire

a year ago

VALNEVA - Declaration of shares and voting rights: December 31, 2023

HRMY or ACAD: Which Is the Better Value Stock Right Now?

Zacks

a year ago

HRMY or ACAD: Which Is the Better Value Stock Right Now?

Forget This 8.8%-Yielding Dividend Stock. Consider These Even Higher-Yielding Payouts Instead.

Motley Fool

a year ago

Forget This 8.8%-Yielding Dividend Stock. Consider These Even Higher-Yielding Payouts Instead.

AC Immune (ACIU) Upgraded to Buy: Here's Why

Zacks

a year ago

AC Immune (ACIU) Upgraded to Buy: Here's Why

AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases

GlobeNewswire

a year ago

AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases

Ceva Extends its Connect IP Portfolio with Wi-Fi 7 Platform for High-End Consumer and Industrial IoT

PR Newswire

a year ago

Ceva Extends its Connect IP Portfolio with Wi-Fi 7 Platform for High-End Consumer and Industrial IoT

What Does Matthews International Corporation's (NASDAQ:MATW) Share Price Indicate?

Simply Wall St.

a year ago

What Does Matthews International Corporation's (NASDAQ:MATW) Share Price Indicate?

Portfolio Powerhouses: 3 Stocks That Could Make You a Millionaire by 2026

InvestorPlace

a year ago

Portfolio Powerhouses: 3 Stocks That Could Make You a Millionaire by 2026

At US$24.48, Is Legacy Housing Corporation (NASDAQ:LEGH) Worth Looking At Closely?

Simply Wall St.

a year ago

At US$24.48, Is Legacy Housing Corporation (NASDAQ:LEGH) Worth Looking At Closely?

Fate Therapeutics (FATE) Upgraded to Buy: Here's Why

Zacks

a year ago

Fate Therapeutics (FATE) Upgraded to Buy: Here's Why

New Strong Sell Stocks for December 22nd

Zacks

a year ago

New Strong Sell Stocks for December 22nd

Better Awards Hardworking Family with Home Giveaway and Launches HOPE Grant to Bolster Home Accessibility

Business Wire

a year ago

Better Awards Hardworking Family with Home Giveaway and Launches HOPE Grant to Bolster Home Accessibility

Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe

Business Wire

a year ago

Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe

Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc

GuruFocus.com

a year ago

Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc

Despegar.com, Corp.'s (NYSE:DESP) Share Price Matching Investor Opinion

Simply Wall St.

a year ago

Despegar.com, Corp.'s (NYSE:DESP) Share Price Matching Investor Opinion

Redwood Trust Inc's Dividend Analysis

GuruFocus.com

a year ago

Redwood Trust Inc's Dividend Analysis

Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight

InvestorPlace

a year ago

Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight

AC Immune Announces Pricing of Underwritten Offering of Common Shares

GlobeNewswire

a year ago

AC Immune Announces Pricing of Underwritten Offering of Common Shares

AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial

GlobeNewswire

a year ago

AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial

Cognyte Announces Third Quarter Fiscal 2024 Results

Business Wire

a year ago

Cognyte Announces Third Quarter Fiscal 2024 Results

Protagonist Reports 2-Year Follow Up Data from Rusfertide REVIVE Study at the ASH Annual Meeting Showing Durable Efficacy and No New Safety Signals

ACCESSWIRE

a year ago

Protagonist Reports 2-Year Follow Up Data from Rusfertide REVIVE Study at the ASH Annual Meeting Showing Durable Efficacy and No New Safety Signals

Is Arlo Technologies, Inc. (NYSE:ARLO) Potentially Undervalued?

Simply Wall St.

a year ago

Is Arlo Technologies, Inc. (NYSE:ARLO) Potentially Undervalued?

Adams Natural Resources Fund Announces $19.96 Issue Price of Shares for Year-End Distribution Payable December 15, 2023

GlobeNewswire

a year ago

Adams Natural Resources Fund Announces $19.96 Issue Price of Shares for Year-End Distribution Payable December 15, 2023

Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 30%?

Simply Wall St.

a year ago

Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 30%?

Olema Pharmaceuticals (OLMA) Skyrockets 471% YTD: Here's Why

Zacks

a year ago

Olema Pharmaceuticals (OLMA) Skyrockets 471% YTD: Here's Why

Share on Social Networks: